- Jones Soda Co. (OTCQB: JSDA) shifts focus to hemp-derived THC products following divestiture of marijuana-derived THC business.
- The Mary Jones HD9 portfolio, featuring sodas, shooters, and gummies, experienced growth for four consecutive quarters through Q1 2025.
- Strong distribution network established with over 26 leading DSD distributors nationwide.
Jones Soda Co. (JSDA, Financial) recently announced its strategic repositioning to strengthen its core business segments by concentrating on its fast-growing hemp-derived THC (HD9) product line, following the divestiture of its marijuana-derived THC business. The company's Mary Jones HD9 portfolio which includes sodas, shooters, and gummies, has achieved notable success with four consecutive quarters of sales growth through the first quarter of 2025.
CEO Scott Harvey emphasized the company’s robust distribution capabilities with over 26 top DSD distributors nationwide, aimed at enhancing the reach and availability of its hemp-infused offerings. This strategic decision to focus on HD9 products is expected to sharpen priorities and accelerate investments in its key categories of soda, functional beverages, and adult beverages.
Headquartered in Seattle, Jones Soda Co. continues to expand its presence in North America, leveraging its innovative approach to brand engagement and product offerings. With a strong emphasis on hemp-derived THC products post-divestiture, the company remains committed to maintaining its growth trajectory in the competitive beverage market.
